BMJ1d
POS0328 ENGRAILED 1 COORDINATES CYTOSKELETAL ORGANIZATION TO PROMOTE MYOFIBROBLAST DIFFERENTIATION AND FIBROTIC TISSUE REMODELING
1 Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Department of Internal Medicine 3 - Rheumatology and Immunology, Erlangen, Germany 2 FAU Erlangen-Nürnberg ...
BMJ2d
Efficacy of COVID-19 vaccines in patients taking immunosuppressants
Correspondence to Dr Lili Zhao, Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA; zhaolili{at}med.umich.edu Objectives We intended to assess the effectiveness of all three ...
BMJ3d
POS0397 SSD6453, A NOVEL AND HIGHLY SELECTIVE BTK/JAK3 DUAL INHIBITOR IS EFFICACIOUS IN MULTIPLE PRE-CLINICAL MODELS OF INFLAMMATION
Background The mechanism of inflammatory diseases is complicated and dysfunction of multiple immune cells is thought to be directly related to the pathogenesis. Targeting either JAK-STAT or BCR ...
BMJ3d
AB1124 The Importance of the Early Rehabilitation after Total Knee Replacement in Osteoarthritis and Rheumatoid Arthritis Patients
Background Total knee replacement (TKR) revolutionized management of patients with advanced knee osteoarthritis and rheumatoid arthritis, in order to help them overcome pain and functional limitation, ...
BMJ3d
AB0412 Preclinical PK and Safety Assessment of the Proposed Adalimumab Biosimilar Gp2017, Compared to Humira®
Background TNFα inhibitors are highly effective drugs for the treatment of inflammatory disorders such as rheumatoid arthritis. Biosimilars are approved biologics with comparable quality, safety and ...
BMJ3d
AB0059 STUDY OF THE ANTI-INFLAMMATORY EFFECT OF CINNAMOMUM VERUM IN RATS
3 University of Sfax, Laboratory of Biochimie, Hedi Chaker Hospital Sfax, Sfax, Tunisia 4 Hedi Chaker Hopital, Laboratory of Biochimie, Sfax, Tunisia 5 Habib Bourguiba Hopital, Laboratory of Histology ...
BMJ4d
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis
Objective To develop and validate revised classification criteria for granulomatosis with polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited into an ...
BMJ4d
Debilitating knee pain in a patient with “normal” radiographs
Dr G K Meenagh, Department of Rheumatology, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BA, UKgarymeenagh{at}yahoo.co.uk If you wish to reuse any or all of ...
BMJ4d
Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial
Dr C H M van den Ende, Leiden University Medical Centre, Department of Rheumatology, C4-R, Postbox 9600, 2300 RC Leiden, The Netherlands Email:e.vandenende{at}nivel.nl OBJECTIVE To investigate the ...
BMJ4d
AB0230 Pre-methotrexate lung screening for interstitial lung disease – is a chest x-ray adequate?
Background Methotrexate (MTX) is the most commonly used disease modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). Methotrexate pneumonitis (MP) is a potentially ...
BMJ5d
OP0089-HPR PILATES IS BETTER THAN WALKING FOR PATIENTS WITH FIBROMYALGIA: A RANDOMIZED CONTROLLED TRIAL
Background Fibromyalgia (FM) is defined as a chronic syndrome characterized by diffuse musculoskeletal pain and several symptoms that reflect on the functional capacity and quality of life of the ...
BMJ5d
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis
1 Department of Anatomy, Histology and Forensic Medicine, University of Florence, Florence, Italy 2 Department of Biomedicine, Division of Rheumatology, AOUC, and Excellence Centre for Research, ...